Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries | BMJ Global Health

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About

Blog

Supplements
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Original research

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries

Online download statistics by month:

Online download statistics by month: October 2020 to May 2022

	Abstract	Full	Pdf
Oct 2020	435	432	81
Nov 2020	286	279	66
Dec 2020	117	112	38
Jan 2021	244	230	80
Feb 2021	126	121	38
Mar 2021	122	116	55
Apr 2021	99	92	37
May 2021	106	101	28
Jun 2021	59	57	22
Jul 2021	112	107	19
Aug 2021	47	44	17
Sep 2021	74	66	34
Oct 2021	73	63	37
Nov 2021	79	76	32
Dec 2021	55	51	18
Jan 2022	73	70	19
Feb 2022	88	84	32
Mar 2022	80	83	24
Apr 2022	118	114	24
May 2022	90	91	31
Total	2483	2389	732